Vismodegib: the proof of concept in Basal cell carcinoma
- PMID: 24932107
- PMCID: PMC4051803
- DOI: 10.4137/CMO.S14569
Vismodegib: the proof of concept in Basal cell carcinoma
Abstract
Although basal cell carcinoma (BCC) is the most common cancer worldwide, its metastatic dissemination is exceptional. Before 2012, we had a few treatment options available for metastatic or locally advanced cases. Management of these patients was complicated due to the lack of scientific data, the deterioration of a patient's general status, the patient's advanced age, and the presence of multiple comorbidities. The hedgehog signaling pathway is dysregulated in BCC. The exploration of this signaling pathway yielded to a major milestone in the treatment of advanced BCC. Vismodegib (GDC-0449), an oral small-molecule agent that targets the Hedgehog signaling pathway, demonstrates high levels of activity in clinical trials. It was approved in January 2012 for the treatment of locally advanced or metastatic BCC. Vismodegib confirms, once again, the interest in exploring the signal transduction pathways in cancers.
Keywords: basal cell carcinoma; cetuximab; hedgehog; vismodegib.
References
-
- World Health Organization Skin cancers 2014. [Accessed on March 24, 2014]. Available from: http://www.who.int/uv/faq/skincancer/en/index.
-
- National Cancer Institute . Definition of skin cancer. Bethesda, MD: National Institutes of Health; 2014. [Accessed on January 1, 2014]. Available from: http://www.cancer.gov/cancertopics/types/skin.
-
- Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw. 2010;8(8):888–96. - PubMed
-
- American Cancer Society . Skin Cancer: Basal and Squamous Cell. Atlanta, GA: American Cancer Society; 2013. [Accessed on January 1, 2014]. Available from: http://documents.cancer.org/acs/groups/cid/documents/webcontent/003139-p....
-
- Dyba T, Hakulinen T, Päivärinta L. A simple non-linear model in incidence prediction. Stat Med. 1997;16(20):2297–309. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources